Does Mounjaro work for everyone — and what affects your results?

Step 1, Understanding what tirzepatide actually changes in your body

To understand why Mounjaro does not work identically for everyone, it helps to start with the mechanism. Tirzepatide activates both the GLP-1 and GIP receptors, two pathways involved in appetite signalling, blood-sugar regulation, and how quickly food leaves the stomach. You can read a detailed explanation of how Mounjaro works on its own page, but the short version is this: the medicine reshapes the hunger signals your brain receives after eating.

Those signals are not uniform across people. Receptor sensitivity, gut-transit speed, baseline insulin response, and metabolic rate all vary. This is why two people on the same dose, following similar diets, can lose different amounts of weight. It does not mean one of them is doing something wrong. The NHS patient information for tirzepatide notes that weight loss depends on individual factors as well as the medicine itself, which is an honest framing worth repeating.

The starting dose (2.5mg) exists to let your digestive system settle into the medicine, not to deliver the full therapeutic effect. Most people spend four weeks there before moving up. The real clinical work begins at the therapeutic doses, and how well those doses suppress appetite is where individual biology plays the biggest role.

Step 2, Who tends to respond well, and where the variation comes from

The SURMOUNT-1 trial, involving 2,539 adults with obesity, found average reductions of around 20–21% body weight at 15mg over 72 weeks. Those are trial averages, and averages obscure a range. Some participants lost substantially more; a portion lost considerably less. Understanding why requires looking at what differentiates them.

Factors associated with a stronger response include: reaching and tolerating the higher doses, making the dietary adjustments the medicine makes easier (eating less, more slowly, with more protein), consistent weekly dosing, and managing any conditions (such as poorly controlled thyroid disease) that independently affect weight. The question of whether everyone loses weight on Mounjaro is explored in its own right elsewhere, but the short answer is: most people do, but not at the same rate or amount.

Hair thinning is one side effect that surprises people and is worth mentioning here. It is generally linked to rapid weight loss rather than the medicine itself. If you are concerned, hair loss on Mounjaro is a topic with its own evidence base worth reading. Separately, a small number of people find weight loss stalls or reverses, sometimes due to hormonal factors, sometimes dose-related, sometimes lifestyle drift. A female-specific perspective on unexplained weight gain during Mounjaro treatment is worth reading if that applies to you.

Step 3 (When tirzepatide does not work as expected, and what the prescriber considers

There is a meaningful difference between "Mounjaro is not working" and "Mounjaro has not worked yet at this dose." A full response to tirzepatide typically takes many months of titration, which is why NICE's appraisal) NICE TA1026, recommends reviewing continuation only at six months on the highest tolerated dose. Stopping early because the 5mg pen produced modest results misreads the medicine's design.

That said, there are genuine situations where tirzepatide is less effective or unsuitable. People with rare hormonal conditions driving their weight, those unable to tolerate any meaningful dose escalation due to persistent side effects, or those for whom the appetite-suppression signal is genuinely blunted, these are real clinical scenarios. The page on who Mounjaro may not work for goes through these in detail, as does the more specific question of why tirzepatide might not be working for you personally.

Routine matters too. The pen lives in the fridge, and a missed dose or inconsistent injection day disrupts the steady-state the medicine needs to work. These are the practical things a prescriber or clinical pharmacist will ask about before assuming the medicine itself is at fault. If you are still weighing up whether tirzepatide is the right medicine for you at all, our tirzepatide overview covers the full clinical picture, and the Mounjaro information page covers the pen format and UK licensing specifically.

Private treatment through a registered pharmacy removes the waiting-list barrier but the clinical rigour stays the same: a prescriber reviews whether the medicine is working, whether the dose should change, and whether continuing makes sense. If you are thinking about cost alongside all of this, a look at Mounjaro prices in the UK explains what the private market looks like. When you are ready to talk it through, starting a free consultation is the practical next step.